SMARCB1 and cancer: The role of DCAF5 was confirmed by CRISPR-based competitive fitness assays and short hairpin RNA (shRNA)-mediated knockdown, showing that DCAF5 is required for the proliferation of SMARCB1-mutant RT lines, but not for cancer cells harbouring other SWI/SNF mutations.